197 related articles for article (PubMed ID: 25696857)
21. Deferasirox improves hematologic and hepatic function with effective reduction of serum ferritin and liver iron concentration in transfusional iron overload patients with myelodysplastic syndrome or aplastic anemia.
Cheong JW; Kim HJ; Lee KH; Yoon SS; Lee JH; Park HS; Kim HY; Shim H; Seong CM; Kim CS; Chung J; Hyun MS; Jo DY; Jung CW; Sohn SK; Yoon HJ; Kim BS; Joo YD; Park CY; Min YH;
Transfusion; 2014 Jun; 54(6):1542-51. PubMed ID: 24313463
[TBL] [Abstract][Full Text] [Related]
22. Iron overload in thalassemia and related conditions: therapeutic goals and assessment of response to chelation therapies.
Porter JB; Shah FT
Hematol Oncol Clin North Am; 2010 Dec; 24(6):1109-30. PubMed ID: 21075283
[TBL] [Abstract][Full Text] [Related]
23. Cardiac iron overload in sickle-cell disease.
Meloni A; Puliyel M; Pepe A; Berdoukas V; Coates TD; Wood JC
Am J Hematol; 2014 Jul; 89(7):678-83. PubMed ID: 24664847
[TBL] [Abstract][Full Text] [Related]
24. Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy.
Brown K; Subramony C; May W; Megason G; Liu H; Bishop P; Walker T; Nowicki MJ
J Pediatr Hematol Oncol; 2009 May; 31(5):309-12. PubMed ID: 19415007
[TBL] [Abstract][Full Text] [Related]
25. Consequences and management of iron overload in sickle cell disease.
Porter J; Garbowski M
Hematology Am Soc Hematol Educ Program; 2013; 2013():447-56. PubMed ID: 24319218
[TBL] [Abstract][Full Text] [Related]
26. Magnetic resonance imaging assessment of cardiac and liver iron load in transfusion dependent patients.
Leung AW; Chu WC; Lam WW; Lee V; Li CK
Pediatr Blood Cancer; 2009 Dec; 53(6):1054-9. PubMed ID: 19618454
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis and management of transfusion iron overload: the role of imaging.
Wood JC
Am J Hematol; 2007 Dec; 82(12 Suppl):1132-5. PubMed ID: 17963249
[TBL] [Abstract][Full Text] [Related]
28. Correlative study of iron accumulation in liver, myocardium, and pituitary assessed with MRI in young thalassemic patients.
Christoforidis A; Haritandi A; Tsitouridis I; Tsatra I; Tsantali H; Karyda S; Dimitriadis AS; Athanassiou-Metaxa M
J Pediatr Hematol Oncol; 2006 May; 28(5):311-5. PubMed ID: 16772883
[TBL] [Abstract][Full Text] [Related]
29. Myocardial iron loading by magnetic resonance imaging T2* in good prognostic myelodysplastic syndrome patients on long-term blood transfusions.
Chacko J; Pennell DJ; Tanner MA; Hamblin TJ; Wonke B; Levy T; Thomas PW; Killick SB
Br J Haematol; 2007 Sep; 138(5):587-93. PubMed ID: 17610536
[TBL] [Abstract][Full Text] [Related]
30. A new era in iron chelation therapy: the design of optimal, individually adjusted iron chelation therapies for the complete removal of iron overload in thalassemia and other chronically transfused patients.
Kontoghiorghes GJ
Hemoglobin; 2009; 33(5):332-8. PubMed ID: 19814679
[TBL] [Abstract][Full Text] [Related]
31. Deferasirox for iron chelation in multitransfused children with sickle cell disease; long-term experience in the East London clinical haemoglobinopathy network.
Tsouana E; Kaya B; Gadong N; Hemmaway C; Newell H; Simmons A; Whitmarsh S; Telfer P
Eur J Haematol; 2015 Apr; 94(4):336-42. PubMed ID: 25138173
[TBL] [Abstract][Full Text] [Related]
32. Monitoring iron status in end-stage renal disease patients on hemodialysis.
Rafi A; Karkar A; Abdelrahman M
Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
[TBL] [Abstract][Full Text] [Related]
33. [Value of magnetic resonance imaging T2* tests in detecting heart and liver iron overload in patients with β-thalassemia major].
Wu X; Jing Y; Pei F; Chen J; Feng X; He Y; Zhang Y; Li C
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):249-52. PubMed ID: 23443782
[TBL] [Abstract][Full Text] [Related]
34. Diagnosing and preventing iron overload.
Ramanathan G; Olynyk JK; Ferrari P
Hemodial Int; 2017 Jun; 21 Suppl 1():S58-S67. PubMed ID: 28328144
[TBL] [Abstract][Full Text] [Related]
35. Pancreatic iron stores assessed by magnetic resonance imaging (MRI) in beta thalassemic patients.
de Assis RA; Ribeiro AA; Kay FU; Rosemberg LA; Nomura CH; Loggetto SR; Araujo AS; Fabron Junior A; de Almeida Veríssimo MP; Baldanzi GR; Espósito BP; Baroni RH; Wood JC; Hamerschlak N
Eur J Radiol; 2012 Jul; 81(7):1465-70. PubMed ID: 21501938
[TBL] [Abstract][Full Text] [Related]
36. Non-invasive assessment of tissue iron overload.
Fischer R; Harmatz PR
Hematology Am Soc Hematol Educ Program; 2009; ():215-21. PubMed ID: 20008201
[TBL] [Abstract][Full Text] [Related]
37. Iron stores assessment in alcoholic liver disease.
Costa Matos L; Batista P; Monteiro N; Ribeiro J; Cipriano MA; Henriques P; Girão F; Carvalho A
Scand J Gastroenterol; 2013 Jun; 48(6):712-8. PubMed ID: 23534461
[TBL] [Abstract][Full Text] [Related]
38. Understanding iron overload: screening, monitoring, and caring for patients with transfusion-dependent anemias.
Ault P; Jones K
Clin J Oncol Nurs; 2009 Oct; 13(5):511-7. PubMed ID: 19793708
[TBL] [Abstract][Full Text] [Related]
39. Burden of iron overload among non-chronically blood transfused preschool children with sickle cell anaemia.
Olufemi AS; Folashade AA; Adetutu OT
Afr Health Sci; 2021 Jun; 21(2):753-758. PubMed ID: 34795732
[TBL] [Abstract][Full Text] [Related]
40. Role of non-invasive assessment in prediction of preclinical cardiac affection in multi-transfused thalassaemia major patients.
Said Othman KM; Elshazly SA; Heiba NM
Hematology; 2014 Oct; 19(7):380-7. PubMed ID: 24225039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
